Clinical Trial Update: Effects of Latanoprost, Bimatoprost and Travoprost in Patients With Latanoprost-resistant Glaucoma [NA]

View source ↗

Summary

A clinical trial evaluating latanoprost, bimatoprost, and travoprost in latanoprost-resistant glaucoma. The study status is UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma
• Ocular Hypertension

Drugs mentioned

• Bimatoprost (Lumigan) (bimatoprost)
• Latanoprost (Xalatan) (latanoprost)
• Travoprost (Travatan Z) (travoprost)

Snippet

Sponsor: Centre de recherche du Centre hospitalier universitaire de Sherbrooke | Conditions: Ocular Hypertension, Primary Glaucoma | NA | Status: UNKNOWN